Page 126 - Haematologica June

K. Kawamoto et al.
2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131.
20. Imai S, Sugiura M, Oikawa O, et al. Epstein-Barr virus (EBV) - carrying and - expressing T-cell lines established from severe chronic active EBV infection. Blood. 1996;87(4):1446-1457.
21. Kawamoto K, Miyoshi H, Yanagida E, et al. Comparison of clinicopathological charac- teristics between T-PLL and PTCL, NOS. Eur J Haematol. 201;98(5):459-466.
22. Kawamoto K, Miyoshi H, Yoshida N, Takizawa J, Sone H, Ohshima K. Clinicopathological, cytogenetic, and prog- nostic analysis of 131 myeloid sarcoma patients. Am J Surg Pathol. 2016;40(11): 1473-1483.
23. Kanda Y. Investigation of the freely avail- able easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48(3):452-458.
24. Cunha BA, Petelin A, George S. Fever of unknown origin (FUO) in an elderly adult due to Epstein-Barr virus (EBV) presenting as "typhoidal mononucleosis," mimicking a lymphoma. Heart Lung. 2013;42(1):79-81.
25. Levy L, Nasereddin A, Rav-Acha M, Kedmi M, Rund D, Gatt ME. Prolonged fever, hepatosplenomegaly, and pancytopenia in a 46-year-old woman. PLoS Med. 2009;6(4):e1000053.
26. Kato S, Takahashi E, Asano N, et al. Nodal cytotoxic molecule (CM)-positive Epstein- Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological
study of 26 cases. Histopathology.
2012;61(2):186-199.
27. Roghmann MC, Warner J, Mackowiak PA.
The relationship between age and fever magnitude. Am J Med Sci. 2001;322(2):68- 70.
28. Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011;117(22):5835-5849.
29. Iwata S, Wada K, Tobita S, et al. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. J Gen Virol. 2010;91(Pt 1):42-50.
30. Bollard CM. Improving T-cell therapy for Epstein-Barr virus lymphoproliferative dis- orders. J Clin Oncol. 2013;31(1):5-7.
31. Shen HQ, Lu M, Ikawa T, et al. T/NK bipo- tent progenitors in the thymus retain the potential to generate dendritic cells. J Immunol. 2003;171(7):3401-3406.
32. Ohga S, Ishimura M, Yoshimoto G, et al. Clonal origin of Epstein-Barr virus (EBV)- infected T/NK-cell subpopulations in EBV- positive T/NK-cell lymphoproliferative dis- orders of childhood. J Clin Virol. 2011;51(1):31-37.
33. Liu S, Zhang Q, Huang D, et al. Comprehensive assessment of peripheral blood TCRbeta repertoire in infectious mononucleosis and chronic active EBV infection patients. Ann Hematol. 2017;96(4):665-680.
34. Katano H, Ali MA, Patera AC, et al.
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood. 2004;103 (4):1244-1252.
35. Kiyasu J, Miyoshi H, Hirata A, et al. Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood. 2015;126(19):2193-2201.
36. Jo JC, Kim M, Choi Y, et al. Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type. Ann Hematol. 2017;96(1):25-31.
37. Ansell SM, Lesokhin AM, Borrello I, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med. 2015;372(4):311-319.
38. Younes A, Santoro A, Shipp M, et al. Nivolumab for classical Hodgkin's lym- phoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single- arm phase 2 trial. Lancet Oncol. 2016;17(9):1283-1294.
39. Kwong YL, Chan TSY, Tan D, et al. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase. Blood. 2017;129(17):2437-2442.
40. Ohtsuka R, Abe Y, Sada E, et al. Adult patient with Epstein-Barr virus (EBV)-associ- ated lymphoproliferative disorder: chronic active EBV infection or de novo extranodal natural killer (NK)/T-cell lymphoma, nasal type? Intern Med. 2009;48(6):471-474.
1028
haematologica | 2018; 103(6)